Ultrasound of the Thoracolumbar Fascia for Diagnosing Chronic Low Back Pain

Imaging Pain! Ultrasound-based Palpation and Visualization for Diagnosing Chronic Low Back Pain

It is estimated that 23% of Quebecers suffer from chronic low back pain, and that 12% are disabled by this condition. Despite medical advances, the origin of so-called 'nonspecific low back pain' remains enigmatic. Conventional imaging methods by computed tomography and magnetic resonance may provide information on vertebral structures. However, very often, they do not diagnose lesions that genuinely correlate with the patient's symptoms. The lack of accurate diagnosis limits the therapeutic management in these patients.

Therefore, patients are increasingly turning to alternative and complementary medicine therapies (e.g., acupuncture, chiropractic , osteopathy, shiatsu) to relieve their pain. These therapies target painful areas of abnormal hardening in muscles of the lower back and aim to release the tension in these tissues to control pain. However, these painful areas and their resolution after manual therapy have yet to be demonstrated by means other than manual palpation. We will conduct a randomized controlled trial in chronic low back pain patients to examine the effects of acupuncture, chiropractic therapy and therapeutic massage on lower back muscular and connective tissues' physical properties using innovative ultrasound techniques.

Study Overview

• Status: Terminated
• Conditions: Low Back Pain
• Intervention / Treatment: Procedure: Manual therapy

Detailed Description

This will be a phase II, prospective, randomized controlled study, which will have received IRB approval and will be registered at Clinicaltrials.gov before it begins. Participants with chronic non specific low back pain (NSLBP) will be recruited from one site. On the day of the registration visit, the participants will meet with the research assistant to review and sign the consent form, give clinical and demographic data and respond to validated outcome questionnaires.

The participants will then undergo a research dynamic ultrasound (US) of the lower back. One musculoskeletal radiologist will perform the US exams consisting of a series of 5 dynamic scans of both the right and left paraspinal muscles, obtained during passive flexion of the lower body. Following the US exam, the participants will be randomized in three groups (allocation 1:1). One group will receive a standardized acupuncture treatment and another group will receive a standardized chiropractic treatment. One treatment session per week for 3 consecutive weeks will be provided. Following the 3 treatment sessions, at week 4, the US exam will be repeated and the questionnaires will be administered.

The third group will be placed on a waiting list for 3 weeks and will be reexamined by US and respond to the questionnaires at week 4. Then, the participants will undergo a standardized therapeutic massage treatment with one treatment session per week for 3 consecutive weeks. Following the 3 treatment sessions, at week 7, the US exam will be repeated and the questionnaires will be administered.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Quebec
    • Montréal, Quebec, Canada, H2X 0C1
      • Centre Hospitalier de l'Université de Montréal

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 75 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Ongoing low back and/or referred pain (non-specific pattern) above or just below the gluteal fold of at least 3/10 on a numerical pain rating scale (NRS), for at least 3 months;
• Pain has resulted in a problem on at least 50% of the days in the past 6 months;
• Only use of oral non-steroidal anti-inflammatory drugs for pain treatment in the 4 weeks before treatment;
• Willingness to commit to treatment sessions (acupuncture, chiropractic therapy or therapeutic massage) and to follow-up visits.

Exclusion Criteria:

• Back pain attributable to a specific, recognizable, known pathology:

  1. protrusion or prolapse of 1 or more intervertebral discs with concurrent neurological symptoms;
  2. radicular pain (sciatica);
  3. infectious spondylopathy;
  4. low back pain caused by inflammatory, malignant, or autoimmune disease;
  5. congenital deformation of the spine (except for slight lordosis or scoliosis);
  6. compression fracture caused by osteoporosis;
  7. spinal stenosis;
  8. spondylolysis or spondylolisthesis;
  9. Pregnancy;
• History of spinal surgery;
• History of pelvis or hip fractures;
• Acupuncture, spinal manipulation or therapeutic massage for back pain within the past year;
• Severe clotting disorders or anticoagulant therapy;

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Acupuncture; The acupuncture treatments will consist of one 45-minute session weekly, for 3 consecutive weeks. The acupuncture treatment protocol will be semi standardized according to usual practice. All patients will be treated with a selection of local and distant points, comprising 10 minutes of insertion time, 30 minutes of needle retention and manipulation to achieve de qi (an irradiating feeling) if possible.	Procedure: Manual therapy; Acupuncture, Chiropractic are recognized complementary medicines and Therapeutic Massage is an alternative healing practice.
Experimental: Waiting list and Therapeutic Massage; The therapeutic massage treatments will consist of one 45-minute session weekly, for 3 consecutive weeks. A technique called Fascial Release will be used. Tension related to back pain is believed to be present not only in the back but also in various parts of the body such as the legs, through the connection of fascia, the membrane that surrounds the muscles. The purpose of this treatment is to reduce the tension connected to the lower back.	Procedure: Manual therapy; Acupuncture, Chiropractic are recognized complementary medicines and Therapeutic Massage is an alternative healing practice.
Experimental: Chiropractic; The chiropractic treatments will consist of one 20-minute session weekly, for 3 consecutive weeks. The Diversified technique is one of the most commonly practiced techniques by chiropractors. In the treatment of low back pain, this technique involves the application of a quick (high-velocity), short (low-amplitude) thrust (adjustment) to the lumbo-pelvic area.	Procedure: Manual therapy; Acupuncture, Chiropractic are recognized complementary medicines and Therapeutic Massage is an alternative healing practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
% shear strain change.	Percent shear strain between the thoracolumbar fascia and the epimysium of the erector spinae muscle.	Change from baseline % shear strain at week 4 (Groups 1, 2 and 3). Change from week-4 % shear strain at week 7 (Group 3).

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quantitative ultrasound marker 'μ' change.	Statistical analysis of the echo envelope: the mean intensity μ. This marker is unitless.	Change from baseline marker 'μ' at week 4 (Groups 1, 2 and 3). Change from week-4 marker 'μ' at week 7 (Group 3)
Quantitative ultrasound marker 'α' change.	Statistical analysis of the echo envelope: the scatterer clustering parameter α. This marker is unitless.	Change from baseline marker 'α' at week 4 (Groups 1, 2 and 3). Change from week-4 marker 'α' at week 7 (Group 3)
Quantitative ultrasound marker 'κ' change.	Statistical analysis of the echo envelope: the structure parameter κ. This marker is unitless.	Change from baseline marker 'κ' at week 4 (Groups 1, 2 and 3). Change from week-4 marker 'κ' at week 7 (Group 3)
Brief Pain Inventory short form 'pain severity' change.	The Brief Pain Inventory short form (BPI-sf) is a self-administered questionnaire used to assess the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The BPI-sf includes the four pain severity items (worst pain in last 24 hours, least pain in last 24 hours, pain on average, pain right now) and the seven interference items (general activity; mood; walking ability; normal work including housework; relations with other people; sleep; enjoyment of life). Each item is scored on an 11-point numerical rating scale (NRS) where 0 indicates no pain and 10 indicates worst pain imaginable. There is no scoring algorithm. The arithmetic mean of the four severity items will be used as measures of pain severity; the arithmetic mean of the seven interference items will be used as a measure of pain interference. The minimum and maximum values are 0 and 10 respectively. A higher score represents a worse outcome.	Change from baseline BPI-sf pain severity at week 4 (Groups 1, 2 and 3). Change from week-4 BPI-sf pain severity at week 7 (Group 3)
Brief Pain Inventory short form 'pain interference' change.	The Brief Pain Inventory short form (BPI-sf) is a self-administered questionnaire used to assess the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The BPI-sf includes the four pain severity items (worst pain in last 24 hours, least pain in last 24 hours, pain on average, pain right now) and the seven interference items (general activity; mood; walking ability; normal work including housework; relations with other people; sleep; enjoyment of life). Each item is scored on an 11-point numerical rating scale (NRS) where 0 indicates no pain and 10 indicates worst pain imaginable. There is no scoring algorithm. The arithmetic mean of the four severity items will be used as measures of pain severity; the arithmetic mean of the seven interference items will be used as a measure of pain interference. The minimum and maximum values are 0 and 10 respectively. A higher score represents a worse outcome.	Change from baseline BPI-sf pain interference at week 4 (Groups 1, 2 and 3). Change from week-4 BPI-sf pain interference at week 7 (Group 3)
Oswestry Disability Index (ODI) change.	Self-administered questionnaire. This test is widely used as a low back functional outcome tool. The minimum and maximum values are 0% and 100% respectively. A higher score means a worse outcome.	Change from baseline ODI at week 4 (Groups 1, 2 and 3). Change from week-4 ODI at week 7 (Group 3)
PROMIS (Patient-Reported Outcomes Measurement Information System) Global Health Scale change.	Self-administered questionnaire. The PROMIS uses T scores. A score of 50 represents the mean of the concepts being measured, in the reference population. The standard deviation is 10. The range is from 0 to 100. Higher scores equals more of the concept being measured, therefore a better global health.	Change from baseline PROMIS Global Health at week 4 (Groups 1, 2 and 3). Change from week-4 PROMIS Global Health at week 7 (Group 3)

Collaborators and Investigators

• Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
• Collaborators: Fonds de la Recherche en Santé du Québec
• Investigators: Principal Investigator: Nathalie J Bureau, MD MSc, Centre hospitalier de l'Université de Montréal (CHUM)

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2022
• Primary Completion (Actual): July 24, 2024
• Study Completion (Actual): July 24, 2024

Study Registration Dates

• First Submitted: April 7, 2021
• First Submitted That Met QC Criteria: April 10, 2021
• First Posted (Actual): April 14, 2021

Study Record Updates

• Last Update Posted (Actual): August 23, 2024
• Last Update Submitted That Met QC Criteria: August 21, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Keywords: Ultrasound imaging; Elastography; Lumbar fascia; Acupuncture therapy; Manipulation, Chiropractic; Massage therapy
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain; Low Back Pain
• Other Study ID Numbers: CE 21.003; 2021-AUDC-284121 (Other Grant/Funding Number: Fonds de recherche du Québec)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No